会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • COMPOSITIONS DERIVED FROM MODIOLUS MODIOLUS AND METHODS FOR MAKING AND USING SAME
    • 从MODIOLUS MODIOLUS衍生的组合物及其制备和使用方法
    • WO0170130A3
    • 2002-02-07
    • PCT/US0109192
    • 2001-03-22
    • UNIV CREIGHTONSFS INCADRIAN THOMAS ECOLLIN PETER D
    • ADRIAN THOMAS ECOLLIN PETER D
    • A61K35/56A61K35/60A61P3/10A61P9/00A61P19/02A61P29/00
    • A61K35/618
    • Disclosed are compositions which include an isolated soft tissue from Modiolus modiolus ("MM") and compositions which include an oil isolated from MM or a portion thereof. Also disclosed are methods of treating adenocarcinoma in a subject; methods of decreasing proliferation of adenocarcinoma cells, or of inducing apoptosis of adenocarcinoma cells, or of inducing differentiation of adenocarcinoma cells into non-cancerous cells; methods of inhibiting the activity of 5-lipoxygenase or 12-lipoxygenase or both in cells; and methods of treating a subject suffering from a disease or condition associated with excessive 5-lipoxygenase activity or 12-lipoxygenase activity or both. A process for preparing an MM extract by contacting MM or a portion thereof with a solvent under conditions effective to extract one or more materials from the MM or portion thereof is also described.
    • 公开了包括来自Modiolus modiolus(“MM”)的分离的软组织的组合物和包含从MM或其一部分分离的油的组合物。 还公开了在受试者中治疗腺癌的方法; 降低腺癌细胞增殖或诱导腺癌细胞凋亡或诱导腺癌细胞分化为非癌细胞的方法; 抑制5-脂氧合酶或12-脂氧合酶或两者在细胞中的活性的方法; 以及治疗患有与过量的5-脂氧合酶活性或12-脂肪氧合酶活性或两者有关的疾病或病症的受试者的方法。 还描述了在有效从MM或其部分提取一种或多种材料的条件下使MM或其一部分与溶剂接触来制备MM提取物的方法。
    • 3. 发明申请
    • OMEGA-5-FATTY ACIDS USEFUL IN LIPOXYGENASE 5 INHIBITION AND IN THE TREATMENT OF CANCER
    • 欧米茄5脂肪酸有助于LIPOXYGENASE 5抑制和治疗癌症
    • WO2008079328A2
    • 2008-07-03
    • PCT/US2007026152
    • 2007-12-22
    • UNIV CREIGHTONADRIAN THOMAS EMURPHY RICHARD F
    • ADRIAN THOMAS EMURPHY RICHARD F
    • A61K31/202
    • A61K31/202
    • Disclosed are omega-5 fatty acids having one of the following formulae: CH 3 - (CH 2 ) 3 -CH=CH- (CH 2 ) 9 -COOH, CH 3 - (CH 2 ) 3 -CH=CH- (CH 2 ) 11 -COOH, CH 3 - (CH 2 ) 3 -CH=CH- (CH 2 ) 13 -COOH, CH 3 - (CH 2 ) 3 -CH=CH-CH 2 -CH=CH- (CH 2 ) 6 -COOH, CH 3 - (CH 2 ) 3 -CH=CH-CH 2 -CH=CH- (CH 2 ) 8 -COOH, CH 3 - (CH 2 ) 3 -CH=CH-CH 2 -CH=CH- (CH 2 ) 10 -COOH, CH 3 - (CH 2 ) 3 -CH=CH-CH 2 -CH=CH-CH 2 -CH=CH- (CH 2 ) 5 -COOH, CH 3 - (CH 2 ) 3 -CH=CH-CH 2 -CH=CH-CH 2 -CH=CH- (CH 2 ) 7 -COOH, and CH 3 - (CH 2 ) 3 -CH=CH-CH 2 -CH=CH-CH 2 -CH=CH-CH2-CH=CH- (CH 2 ) 4 -COOH and pharmaceutically acceptable esters, salts, amides, and solvates thereof, as well as pharmaceutical compositions which include one or more of aforementioned omega-5 fatty acids and pharmaceutically acceptable esters, salts/ amides, and solvates thereof. Also disclosed are methods of inhibiting 5 -lipoxygenase activity; methods of decreasing proliferation of adenocarcinoma cells, or of inducing apoptosis of adenocarcinoma cells, or of inducing differentiation of adenocarcinoma cells into non-cancerous cells; and methods of treating adenocarcinoma in a subject using one or more of aforementioned omega-5 fatty acids and pharmaceutically acceptable esters, salts, amides, and solvates thereof.
    • 公开了具有下式之一的ω-5脂肪酸:CH 3 - (CH 2 CH 2)3 -CH = CH-(CH 9 - (CH 2)3 - (CH 2)3 - - - - (CH 2)3 - CH = CH-(CH 2)11 - ,-COOH,CH 3 - (CH 2) 3 -CH = CH-(CH 2)13 -COOH,CH 3 - (CH 2) 3)-CH = CH-CH 2 -CH = CH-(CH 2 CH 2)6 - COOH,CH 3 - (CH 2)3 -CH = CH-CH 2 -CH = CH- (CH 2)2 -COOH,CH 3 - (CH 2 2)3 -CH = CH-CH 2 -CH = CH-(CH 2 CH 2)10 -COOH,CH 3 N / > - (CH 2)3 - - CH = CH-CH 2 -CH = CH-CH 2 - CH = CH-(CH 2 CH 2)5 -COOH,CH 3 - (CH 2 CH 2) 3 -CH = CH-CH 2 -CH = CH-CH 2 -CH = CH-(CH 2 CH 2)< (CH 2)3 -CH = CH-CH 2(CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 3)
    • 4. 发明申请
    • METHODS FOR INDUCING APOPTOSIS AND INHIBITING PROLIFERATION IN CANCER CELLS
    • 诱导癌症和抑制癌细胞增殖的方法
    • WO02051406A9
    • 2003-05-01
    • PCT/US0149689
    • 2001-12-24
    • UNIV CREIGHTONSFS INCADRIAN THOMAS ECOLLIN PETER
    • ADRIAN THOMAS ECOLLIN PETER
    • A61K31/201A61P35/00A61K31/22A61K31/20
    • A61K31/201
    • Disclosed are methods of decreasing proliferation of adenocarcinoma cells, or of inducing apoptosis of adenocarcinoma cells, or of inducing differentiation of adenocarcinoma cells into non-cancerous cells. The methods include contacting a sample comprising adenocarcinoma cells with a compound having the formula ("Formula I"): CH3-(CH2)n-CH=CH-(CH2)m-COOH) wherein n is an integer from 0 to 15, m is an integer from about 1 to 16, and the sum of m and n is an integer from 6 to 16, or a pharmaceutically acceptable ester, salt, amide, solvate, or metabolite thereof. Also disclosed are methods for treating adenocarcinoma in a subject. The methods include administering to the subject an effective amount of a compound having Formula I or a pharmaceutically acceptable ester, salt, amide, solvate, or metabolite thereof.
    • 公开了减少腺癌细胞增殖或诱导腺癌细胞凋亡或诱导腺癌细胞分化成非癌细胞的方法。 所述方法包括使包含腺癌细胞的样品与具有式(“式I”)的化合物接触:CH 3 - (CH 2)n -CH = CH-(CH 2)m -COOH)其中n为0至15的整数, m为约1至16的整数,m和n的和为6至16的整数,或其药学上可接受的酯,盐,酰胺,溶剂合物或代谢物。 还公开了治疗受试者中腺癌的方法。 所述方法包括向受试者施用有效量的具有式I的化合物或其药学上可接受的酯,盐,酰胺,溶剂合物或代谢物。
    • 6. 发明专利
    • NO20025343D0
    • 2002-11-07
    • NO20025343
    • 2002-11-07
    • UNIV CREIGHTON
    • ADRIAN THOMAS E
    • A61K45/00A61K31/00A61K31/192A61K31/194A61K31/352A61K31/41A61P35/00A61P43/00A61K
    • Disclosed are methods of decreasing proliferation of adenocarcinoma cancer cells, or of inducing apoptosis of adenocarcinoma cancer cells, or of inducing differentiation of adenocarcinoma cancer cells into non-cancerous cells. One such method includes contacting the adenocarcinoma cancer cells with a compound under conditions effective for the compound to inhibit binding of leukotriene B4 to leukotriene B4 receptor. In another such method, the method includes contacting the adenocarcinoma cancer cells with 2-(2-propyl-3-(3-(2-ethyl-4-(4-fluorophenyl)-5-hydroxyphenoxy)propoxy)phenoxy)benzoic acid or a pharmaceutically acceptable salt, solvate, or congener thereof. Also disclosed are methods of treating adenocarcinomas in a subject. One method includes administering to the subject an amount of a compound effective to inhibit binding of leukotriene B4 to leukotriene B4 receptor. Another method includes administering 2-(2-propyl-3-(3-(2-ethyl-4-(4-fluoropheyl)-5-hydroxyphenoxy)propoxy)phenoxy)benzoic acid or a pharmaceutically acceptable salt, solvate, or congener thereof, to the subject.